TY - JOUR AU - Soria, J. C. AU - Tan, D. S. AU - Chiari, R. PY - 2017 DA - 2017// TI - First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomized, open-label, phase 3 study JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)30123-X DO - 10.1016/S0140-6736(17)30123-X ID - Soria2017 ER - TY - JOUR AU - Kim, D. W. AU - Mehra, R. AU - Tan, D. S. PY - 2016 DA - 2016// TI - Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicenter, open-label, phase 1 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(15)00614-2 DO - 10.1016/S1470-2045(15)00614-2 ID - Kim2016 ER - TY - JOUR AU - Crinò, L. AU - Ahn, M. J. AU - De Marinis, F. PY - 2016 DA - 2016// TI - Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: results from ASCEND-2 JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.65.5936 DO - 10.1200/JCO.2015.65.5936 ID - Crinò2016 ER - TY - STD TI - Felip E, Orlov S, Park K, et al. Phase 2 study of ceritinib in ALKi-naïve patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC): whole body responses in the overall pts group and in pts with baseline brain metastases (BM). Ann Oncol. 2016;27(6) Meeting Abstract: 1208O. https://academic.oup.com/annonc/article/27/suppl_6/1208O/2800066. UR - https://academic.oup.com/annonc/article/27/suppl_6/1208O/2800066 ID - ref4 ER - TY - JOUR AU - Shaw, A. T. AU - Kim, T. M. AU - Crinò, L. PY - 2017 DA - 2017// TI - ASCEND-5: a randomized, phase3 study of ceritinib versus chemotherapy in adult patients with ALK-rearranged non-small cell lung cancer, previously treated with chemotherapy and crizotinib JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30339-X DO - 10.1016/S1470-2045(17)30339-X ID - Shaw2017 ER - TY - JOUR AU - Hirano, T. AU - Yamada, M. AU - Ichinose, M. PY - 2017 DA - 2017// TI - Chronic cholestasis with dilation of intrahepatic bile duct related to Administration of Ceritinib JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2017.04.006 DO - 10.1016/j.jtho.2017.04.006 ID - Hirano2017 ER - TY - JOUR AU - Boraschi, D. AU - Dinarello, C. PY - 2006 DA - 2006// TI - IL-18 in autimmunity: review JO - Eur Cytokine Netw VL - 17 ID - Boraschi2006 ER - TY - JOUR AU - Yamamoto, T. AU - Higashi, T. AU - Nouso, K. PY - 2000 DA - 2000// TI - Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis JO - Clin Exp Immunol VL - 122 UR - https://doi.org/10.1046/j.1365-2249.2000.01356.x DO - 10.1046/j.1365-2249.2000.01356.x ID - Yamamoto2000 ER - TY - JOUR AU - Hirano, T. AU - Kikuchi, T. AU - Tode, N. PY - 2016 DA - 2016// TI - OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia JO - EMBO Mol Med VL - 8 UR - https://doi.org/10.15252/emmm.201506154 DO - 10.15252/emmm.201506154 ID - Hirano2016 ER - TY - JOUR AU - Raffaele, C. AU - Alastair, G. AU - Rohit, L. PY - 2017 DA - 2017// TI - Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer JO - Lung Cancer VL - 111 UR - https://doi.org/10.1016/j.lungcan.2017.06.004 DO - 10.1016/j.lungcan.2017.06.004 ID - Raffaele2017 ER - TY - JOUR AU - Hirota, M. AU - Shibata, M. AU - Ogawa, M. PY - 2002 DA - 2002// TI - Increased plasma concentrations of interleukin-18 in patients with hepatic failure 1 week after surgery JO - J Immunother VL - 25 UR - https://doi.org/10.1097/00002371-200203001-00013 DO - 10.1097/00002371-200203001-00013 ID - Hirota2002 ER - TY - JOUR AU - Naumnik, W. AU - Chyczewska, E. AU - Kovalchuk, O. PY - 2004 DA - 2004// TI - Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer JO - Rocz Akad Med Bialymst VL - 49 ID - Naumnik2004 ER - TY - JOUR AU - Ludwiczek, O. AU - Kaser, A. AU - Novick, D. PY - 2002 DA - 2002// TI - Plasma levels of interleukin-18 and interleukin18 binding protein are elevated in patients with chronic liver disease JO - J Clin Immnol VL - 22 UR - https://doi.org/10.1023/A:1020600230977 DO - 10.1023/A:1020600230977 ID - Ludwiczek2002 ER -